Clinical Trial Update: CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study

View source ↗

Summary

The CLIMB study, conducted by Royal Marsden NHS Foundation Trust, investigates imaging and molecular biomarkers for central nervous system lymphoma and is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: CNS Lymphoma | Status: RECRUITING